By Kevin Richards Industry Vice President, Reed ExhibitionsThere’s a lot that’s new in the biotech industry these days. So far this year, the FDA has approved eight new drugs and diagnostics coming from biotech companies. The industry has raised nearly $15 billion in new capital. The federal government has begun awarding lucrative contracts for defenses against bioterror threats. Recent successes have put biotech companies on a more even footing with their “Big Pharma” partners. And investors are bullish on biotech again.
Likewise, there’s a lot that’s new and exciting at BIOPHEX2004. This year’s all-new conference program, developed by Genetic Engineering News, provides fresh insights on today’s top-priority issues, including process innovation, drug delivery as a strategic asset, knowledge management and technology transfer, and the shrinking biotech plant. And that’s just the beginning!
Free keynote on the future of DNA analysisWhat are the newest technologies available for accelerating the drug development process-and what exciting advances are on the horizon? An expert panel of researchers from industry and academia will provide answers and insights on Thursday, September 30th, from 11:30am to 12:30pm. This probing discussion will be moderated by Shelley Chu, MD, PhD, Principal of Flagship Ventures, an entrepreneurship and venture capital firm focused on creating, financing, and building companies in the life science, information technology, and communications sectors. Panelists include Boris Bastain, M.D., Asst. Professor, Departments of Dermatology & Pathology, UCSF: Larry Goldstein, PhD, Professor of Cellular Molecular Biology, University of San Diego and Investigator, Howard Hughes Medical; Richard S. Judson, PhD, Chief Scientific Officer/Senior VP, Research & Development, Genaissance Pharmaceuticals; plus other distinguished scientists to be announced.
Free special presentation on cannabis-based medicationsAre cannabis-based medications the next big thing in biotech? Join us on Wednesday, September 29th at 11:30am as an all-star panel of pioneering doctors and scientists, moderated by Bill Breen, Senior Projects Editor, Fast Company magazine, delivers a front-line report on the latest research into controversial cannabis medicines and their emerging markets in Europe and beyond. A late breaking addition to the BIOPHEX conference, the panel discussion is based on a series of relevant Fast Company articles covering this dynamic subject.
A new pavilion focused on biopharm facilitiesGet ready to scale up from lab to pilot production, or from pilot to full scale commercial processing! As more new biopharmaceuticals reach late stage development, the need to ensure manufacturing capacity becomes critical. The new Biopharm Facilities Pavilion at BIOPHEX is the perfect complement to our conference sessions on “The Shrinking Biotech Plant.” This is where you will find suppliers with innovative strategies and equipment for maximizing the production capacity of your existing facilities. For those planning a new facility, architectural and engineering firms will be on hand, as well as real estate professionals and representatives from government agencies and utilities offering special incentives for companies relocating to their area.
New “Excellence in Biotechnology” AwardsIn recognition of the industry’s outstanding achievers, BIOPHEX sponsor Genetic Engineering News will honor twelve individuals (six winners and six honorable mentions) for scientific creativity and the focused application of a technology, service or product in the biotech arena. Winners will be selected from nominees submitted by their peers in the industry, based on work that advances the state of biotech science and benefits individuals working in the field.
Preview the latest research results.Back again by popular demand, the BIOPHEX Poster Presentations will feature results of breakthrough research being conducted by individual scientists, universities and research centers. Between 12:30pm and 2:00pm on Wednesday, September 29th, presenters will be on hand to discuss their projects, and Genetic Engineering News will present the “Best Poster” award. Posters will remain on display throughout all three days of the BIOPHEX event.
Meet, mix and mingle at the Opening Night Reception.All badgeholders, including show attendees, exhibitors, conferees and speakers, are invited to this exciting networking event on Wednesday, September 29th. You’ll enjoy cool beverages, hot hors d’oeuvres and the company of your peers. The highlight of the evening will be the presentation of the “Excellence in Biotechnology” Awards by the editors of Genetic Engineering News.
Discover new solutions and new suppliersThe BIOPHEX exhibition is your opportunity to make up-close, hands-on evaluations of advanced solutions and services from more than 200 exhibiting companies, including Allegheny Bradford Corporation; Aseptic Technologies; AssurX, Inc.; Beckman Coulter, Inc.; Carlisle Life Sciences; Commissioning Agents Inc.; Document Control Systems, Inc.; DSM Pharmaceuticals, Inc.; Eagle Stainless Container; Flow Sciences, Inc.; GEA Liquid Processing; Getinge USA, Inc.; IMA North America, Inc.; Lancer USA Inc.; Miele Professional Products; Munters Corporation; Niro Pharma Systems; O’Hara Technologies; OSI Soft, Inc.; Powdersize, Inc.; ProBioGen AG; Robatel, Inc.; Steris Corporation; Swagelok Company; Validation Technologies, Inc.; WESCO Lab Gases and many more.
BIOPHEX2004 will take place September 28-30, 2004 at the Moscone Convention in San Francisco, California. The exhibition opens on Wednesday, September 29. For complete event information (including an up-to-date exhibitor list and floor plan, conference details, special events and convenient on-line registration) please visit http://www.biophex.com.